Eikon Therapeutics, Inc. Common Stock

EIKN XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

520M

Short interest (May 15)

6.7%

Net Short (Jun 03 ): 0.1%

Borrow Fee

4.15%

↓ 14.5%

Available Shares

90K

↓ 50.6%

Price Chart

Company Overview

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001861123

Asset Type: CS

Market Data

Market Cap: $519,730,828

Employees: 384

Status: Active

Short Interest

Current Borrow Fee 4.15%

Range: 4.12% - 4.15%

Available Shares 90K

Range: 90K - 100K

Recent Changes

Fee Change: ↑ 2.0%

Available Change: ↓ 5.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime